Ledger. Australian venture funding, tracked

Startup · $469.7k raised

ProGenis Pharmaceuticals

Developing nucleic acid therapy for aortic stenosis

What ProGenis Pharmaceuticals bought

Companies ProGenis Pharmaceuticals acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company KindAnnounced Price Sources
ProGenis Pharmaceuticals is not recorded as having acquired anything.

Something wrong? Tell us